Clinical Trials

  • Pritzker signs Manar proposal to cover cancer clinical trials for Medicaid beneficiaries

    manar 031120SPRINGFIELD – Illinois Medicaid recipients are now eligible for life-saving clinical trials to treat cancer and other serious diseases.

    This afternoon, Governor Pritzker enacted Senate Bill 1864, a health care package that includes a proposal by Senator Andy Manar (D-Bunker Hill) requiring the state’s Medicaid program to cover routine care costs incurred for an approved clinical trial involving the prevention, detection, or treatment of cancer or any other life-threatening disease, as long as Medicaid would normally cover those same routine care costs for a non-clinical procedure.

    “It’s not an exaggeration to say that this law will save lives. For too long, some people were granted access to the most advanced and potentially life-saving cancer treatment, and others weren’t, simply depending on which insurance plan they had. That injustice ended today,” Manar said. “I appreciate Governor Pritzker’s demonstrated commitment to advancing equity in health care.”

    Initially introduced and carried through the Senate by Manar, the initiative was included in a broader health care package passed by the General Assembly during the abbreviated special session in May.

    More than 20% of Illinoisans are covered by Medicaid, making it the second largest type of insurance behind Medicare.

    Medicare and private insurance carriers are already required to provide coverage for routine care costs in clinical trial participation. Medicaid is not. This legislation would align Medicaid coverage for clinical trials with coverage under those insurance plans.

    Because routine costs would be paid for by Medicaid if the patient were not on a clinical trial, there is minimal cost difference for Medicaid to cover these costs within a clinical trial.

    Manar worked closely with the American Cancer Society to draft the proposal.

    “The state has taken an important step to ensure the viability of new cancer research in our state and to allow an additional 20% of Illinois residents to have access to the latest treatments and therapies,” said Shana Crews, Government Relations Director at the American Cancer Society Cancer Action Network. “We look forward to working with state leaders to further reduce Illinois’ cancer burden.”

  • General Assembly approves Manar measure to cover cancer clinical trials for Medicaid beneficiaries

    cancertrial 052720SPRINGFIELD – With Gov. Pritzker’s signature, Illinois Medicaid recipients would be eligible for life-saving clinical trials to treat cancer and other serious diseases.

    During the abbreviated session last week, the Illinois General Assembly approved a plan by State Senator Andy Manar (D-Bunker Hill) that would require Medicaid to cover routine care costs incurred for an approved clinical trial involving the prevention, detection, or treatment of cancer or any other life-threatening disease, as long as Medicaid would normally cover those same routine care costs for a non-clinical procedure.

    “This is a major stride toward health care equity that will save lives. Access to the latest, most advanced cancer treatments can mean the difference between life and death for patients, treatments that they are unable to access today,” Manar said. “The type of insurance you have shouldn’t disqualify you from accessing treatment that could save your life.”

    More than 20% of Illinoisans are covered by Medicaid, making it the second largest type of insurance behind Medicare.

    Medicare and private insurance carriers are already required to provide coverage for routine care costs in clinical trial participation. Medicaid is not. This legislation would align Medicaid coverage for clinical trials with coverage under those insurance plans.

    Because routine costs would be paid for by Medicaid if the patient were not on a clinical trial, there is minimal cost difference for Medicaid to cover these costs within a clinical trial.

    This legislation was an initiative of the American Cancer Society.

    “We thank the legislature for taking this step and look forward to working with them to continue to reduce Illinois’ cancer burden in the near future,” said Shana Crews, Government Relations Director at the American Cancer Society Cancer Action Network.

  • Hunter helps pass legislation to cover cancer clinical trials for Medicaid beneficiaries

    hunter floor 0523SPRINGFIELD – With Gov. Pritzker’s signature, Illinois Medicaid recipients would be eligible for life-saving clinical trials to treat cancer and other serious diseases.

    “We know that African-Americans are significantly underrepresented among those who participate in clinical trials, meaning we lose out on life-saving opportunities and unanswered questions then remain on the effectiveness of these medications for blacks,” said State Senator Mattie Hunter (D-Chicago). “Because Medicaid recipients are much more diverse, this measure will help reduce that disparity for black patients and for low-income white residents, while advancing the overall fight against cancer.”

  • Manar advances measure to cover cancer clinical trials for Medicaid beneficiaries

    Sen. Andy ManarSPRINGFIELD – Illinois Medicaid recipients considering clinical trials for cancer treatment would no longer face possible rejection of coverage for care under legislation advanced out of the Senate Human Services Committee by State Senator Andy Manar (D-Bunker Hill) on Wednesday.

    “Access to the latest, most advanced cancer treatments can mean the difference between life and death for patients,” Manar said. “I take issue with the fact that some people are granted that access and others aren’t, simply depending on which insurance plan they have. This legislation solves that.”

    An initiative of the American Cancer Society, Senate Bill 2499 requires Medicaid to cover routine care costs incurred for an approved clinical trial involving the prevention, detection, or treatment of cancer or any other life-threatening disease, as long as Medicaid would normally cover those same routine care costs for a non-clinical procedure.